David Altshuler - Feb 24, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Global Research and CSO
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 24, 2022
Transactions value $
-$3,124,808
Form type
4
Date filed
2/28/2022, 04:18 PM
Previous filing
Feb 22, 2022
Next filing
Jul 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$1.38M -6.04K -12.15% $227.86 43.6K Feb 24, 2022 Direct
transaction VRTX Common Stock Sale -$239K -1.04K -2.38% $229.41 42.6K Feb 25, 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$735K -3.19K -7.48% $230.62 39.4K Feb 25, 2022 Direct F1, F3, F4
transaction VRTX Common Stock Sale -$645K -2.78K -7.06% $231.64 36.6K Feb 25, 2022 Direct F1, F3, F5
transaction VRTX Common Stock Sale -$130K -560 -1.53% $232.68 36.1K Feb 25, 2022 Direct F1, F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
F2 Open market sales reported on this line occurred at a weighted average price of $229.41 (range $228.91 to $229.81).
F3 Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F4 Open market sales reported on this line occurred at a weighted average price of $230.62 (range $230.07 to $231.05).
F5 Open market sales reported on this line occurred at a weighted average price of $231.64 (range $231.08 to $232.07).
F6 Open market sales reported on this line occurred at a weighted average price of $232.68 (range $232.43 to $232.87).